Literature DB >> 35092220

Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review.

Garyfallia Pepera1, Marina-Sofia Tribali1, Ladislav Batalik2,3, Ivo Petrov4, Jannis Papathanasiou5,6.   

Abstract

BACKGROUND: Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from China, the novel coronavirus disease 2019 (COVID-19) has caused more than five milion deaths worldwide. Several studies have elucidated the role of risk factors in the prognosis of cardiovascular disease (CVD) in the progression of COVID-19 pandemic. This systematic review assesses the link between COVID-19 and cardiovascular risk factors, and investigates the prognosis in the case of myocardial injury.
METHODS: A literature search was performed to identify relevant articles in Pubmed, MEDLINE, Elsevier, and Google Scholar the last two years using the terms: COVID-19, CVD, risk factors, cardiovascular risk factors, SARS-CoV-2, lockdown, hypertension, and diabetes mellitus. Exclusion criteria were the studies associated with pediatric and pregnant COVID-19 patients.
RESULTS: After screening through 3071 articles, 10 studies were included in this review that captured the findings from 3912 participants. Included studies found that preexisting CVD was linked to worse outcomes and increased risk of death in patients with COVID-19, whereas COVID-19 itself also induced myocardial injury, arrhythmia, acute coronary syndrome, and venous thromboembolism.
CONCLUSIONS: Cardiovascular risk factors such as hypertension, diabetes mellitus, and obesity were associated with intensive care unit admission and poor prognosis. Cardiovascular risk factors are crucial for the progression of COVID-19, and infected patients should be constantly monitored and follow strict hygiene and decrease their social interactions.
© 2022 The Author(s). Published by IMR Press.

Entities:  

Keywords:  COVID-19; Cardiovascular disease; Cardiovascular risk factors; Coronavirus disease pandemic; Epidemiology; Prognosis; Risk factors; SARS-CoV-2; Systematic review

Mesh:

Year:  2022        PMID: 35092220     DOI: 10.31083/j.rcm2301028

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  5 in total

1.  Clinical Factors Associated with COVID-19 Severity in Chronic Hospitalized Infants and Toddlers: Data from a Center in the West Part of Romania.

Authors:  Alina Domnicu; Mirela Mogoi; Aniko Manea; Eugen Radu Boia; Marioara Boia
Journal:  Healthcare (Basel)       Date:  2022-04-27

Review 2.  Effectiveness of Home-Based Cardiac Rehabilitation, Using Wearable Sensors, as a Multicomponent, Cutting-Edge Intervention: A Systematic Review and Meta-Analysis.

Authors:  Varsamo Antoniou; Constantinos H Davos; Eleni Kapreli; Ladislav Batalik; Demosthenes B Panagiotakos; Garyfallia Pepera
Journal:  J Clin Med       Date:  2022-06-29       Impact factor: 4.964

3.  Eight Weeks of Supervised Pulmonary Rehabilitation Are Effective in Improving Resting Heart Rate and Heart Rate Recovery in Severe COVID-19 Patient Survivors of Mechanical Ventilation.

Authors:  María Fernanda Del Valle; Jorge Valenzuela; Gabriel Nasri Marzuca-Nassr; Consuelo Cabrera-Inostroza; Mariano Del Sol; Pablo A Lizana; Máximo Escobar-Cabello; Rodrigo Muñoz-Cofre
Journal:  Medicina (Kaunas)       Date:  2022-04-05       Impact factor: 2.948

4.  Initiation of antihypertensive drugs to patients with confirmed COVID-19-A population-based cohort study in Sweden.

Authors:  Salar Issa Mousa; Fredrik Nyberg; Mohammadhossein Hajiebrahimi; Rebecka Bertilsson; Jonatan Nåtman; Ailiana Santosa; Björn Wettermark
Journal:  Basic Clin Pharmacol Toxicol       Date:  2022-07-06       Impact factor: 3.688

Review 5.  COVID-19 and the heart.

Authors:  Andrew Xanthopoulos; Angeliki Bourazana; Grigorios Giamouzis; Evangelia Skoularigki; Apostolos Dimos; Alexandros Zagouras; Michail Papamichalis; Ioannis Leventis; Dimitrios E Magouliotis; Filippos Triposkiadis; John Skoularigis
Journal:  World J Clin Cases       Date:  2022-10-06       Impact factor: 1.534

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.